Abstract
Fas ligand (FasL) mediates apoptosis of Fas-bearing cells and is expressed on a limited number of tissues, predominantly activated T lymphocytes. We describe the construction and biological activity of a replication-deficient type-5 adenovirus encoding murine FasL under the control of the cytomegalovirus (CMV) promoter (adCMV-FasL). In vitro, Jurkat cells undergo apoptosis when co-incubated with adCMV-FasL-infected COS cells. Systemic administration of adCMV-FasL to Wistar rats or DBA/2J mice results in widespread hepatic apoptosis and death in a dose-dependent manner within 72 hr, an effect not seen in lpr mice, or animals administered equivalent doses of adCMV-βgal. Murine pancreatic islets also undergo apoptosis when infected ex vivo with adCMV-FasL, resulting in uniform primary nonfunction when transplanted into syngeneic or allogeneic diabetic recipients. These results indicate that adCMV-FasL is a potentially useful tool to study Fas/FasL biology.
Overview summary
Expression of Fas ligand (FasL) has recently been associated with immune privilege, and has been shown to prolong pancreatic islet allograft survival when expressed on co-transplanted syngeneic myoblasts. To explore the possibility of using Fas-mediated apoptosis as a tool to destroy activated T cells in an organ transplant setting, we have generated a replication-deficient type-5 adenovirus encoding murine FasL under the control of the cytomegalovirus (CMV) promoter (adCMV-FasL). In this paper, we demonstrate that adCMV-FasL is a potent inducer of apoptosis in vitro and in vivo. Furthermore, ex vivo infection of pancreatic islet isografts and allografts with adCMV-FasL resulted in widespread apoptosis of the islets and dramatically reduced survival in a murine pancreatic islet transplant model. These data suggest that adCMV-FasL may be a useful tool to further study Fas/FasL biology, but its ability to induce apoptosis of transduced grafts effectively is detrimental in the transplant setting.
Get full access to this article
View all access options for this article.